Back to BAKER BROS. ADVISORS LP

CLDX
Showing 8 of 10 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in CELLDEX THERAPEUTICS INC NEW

BAKER BROS. ADVISORS LP holds 665,370 shares of CLDX (CELLDEX THERAPEUTICS INC NEW), worth $21.1M as of 2026-Q1. CLDX represents 0.1% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$21.1M

Current Shares

665,370

Total Value Change

+$11.9M

Total Shares Change

+417,726

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
665,370
0.0%
$21.1M0.1%$28.94
0
2025-Q4
Unchanged
665,370
0.0%
$18.1M0.1%$26.43
0
2025-Q3
Unchanged
665,370
0.0%
$17.2M0.1%$26.19
0
2025-Q2
Increased
665,370
+168.7%
$13.5M0.1%$20.29
54
2025-Q1
Unchanged
247,644
0.0%
$4.5M0.0%$19.93
0
2024-Q4
Unchanged
247,644
0.0%
$6.3M0.1%$25.12
0
2024-Q3
Unchanged
247,644
0.0%
$8.4M0.1%$33.20
0
2024-Q2
Unchanged
247,644
0.0%
$9.2M0.1%$37.01
0

Other major holders of CLDX: WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used